Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem

Bibliography

• Snowden FM. Emerging and reemerging diseases: a historical perspective. Immunol Rev 2008;225:9-26
   PubMed Web of Science ®Google Scholar
• Yang X, Yang H, Zhou G, Zhao GP. Infectious disease in the genomic era. Annu Rev Genomics Hum Genet 2008;9:21-48
   PubMed Web of Science ®Google Scholar
• Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature 2008;451(7181):990-3
   PubMed Web of Science ®Google Scholar
• Soto SM. Human migration and infectious diseases. Clin Microbiol Infect 2009;15(Suppl 1):26-8
   PubMed Web of Science ®Google Scholar
• Seow Y, Wood MJ. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 2009;17(5):767-77
   PubMed Web of Science ®Google Scholar
• Bouard D, Alazard-Dany N, Cosset FL. Viral vectors: from virology to transgene expression. Br J Pharmacol 2009;2157(2):153-65
   Google Scholar
• Beloqui A, de María PD, Golyshin PN, Ferrer M. Recent trends in industrial microbiology. Curr Opin Microbiol 2008;11(3):240-8
   PubMed Web of Science ®Google Scholar
• Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am 2008;26(2):517-47
   PubMed Web of Science ®Google Scholar
• Samaras SC, Dietz N. Physiopathology of dextoxification of pentobarbital sodium. Fed Am Soc Exp Biol 1953;12:122-5
   Google Scholar
• Kato R, Nakamura Y, Chiesara E. Enhanced phenobarbital induction of liver microsomal drug-metabolizing enzymes in mice infected with murine hepatitus virus. Biochem Pharmacol 1963;12:365-70
   PubMed Web of Science ®Google Scholar
• Leeson GA, Biedenback SA, Chan KY, et al. Decrease in activity of the drug metabolizing enzymes of the rat following the administration of tilorone hydrochloride. Drug Metab Dispos 1976;4(3):232-8
   PubMed Web of Science ®Google Scholar
• Renton KW, Mannering GJ. Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents. Biochem Biophys Res Commun 1976;73(2):343-8
   PubMed Web of Science ®Google Scholar
• Singh G, Renton KW. Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation. Mol Pharmacol 1981;20(3):681-4
   PubMed Web of Science ®Google Scholar
• Renton KW. Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus. Biochem Pharmacol 1981;30(16):2333-6
   PubMed Web of Science ®Google Scholar
• Chow HH, Tang Y, Li P, et al. The effect of chronic retrovirus infection and immune dysfunction on the P-450-mediated activation of acetaminophen in mouse liver microsomes. Biopharm Drug Dispos 1998;19(1):9-15
   PubMed Web of Science ®Google Scholar
• Meredith CG, Christian CD, Johnson RF, et al. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther 1985;37(4):396-401
   PubMed Web of Science ®Google Scholar
• Renton KW. Relationships between the enzymes of detoxication and host defense mechanisms. In: Caldwell J, Jacoby WB, editors, Biological Basis of Detoxication. New York: Academic Press; 1983. p. 307-24
   Google Scholar
• Williams SJ, Baird-Lambert JA, Farrell GC. Inhibition of theophylline metabolism by interferon. Lancet 1987;2(8565):939-41
   PubMed Web of Science ®Google Scholar
• Chen YL, Le Vraux V, Leneveu A, et al. Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther 1994;55(6):649-60
   PubMed Web of Science ®Google Scholar
• Gidal BE, Reiss WG, Liao JS, Pitterle ME. Changes in interleukin-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokinetics. Ann Pharmacother 1996;30(5):545-6
   PubMed Web of Science ®Google Scholar
• Shedlofsky SI, Israel BC, McClain CJ, et al. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest 1994;94(6):2209-14
   PubMed Web of Science ®Google Scholar
• Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1978;1(8074):1132-3
   PubMed Web of Science ®Google Scholar
• Reiss WG, Piscitelli SC. Drug-cytokine interactions: mechanisms and clinical implications. Biodrugs 1998;9(5):389-95
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, He P, von Moltke LL, Court MH. The CYP3 Family. In: Ioannides C, editor, Cytochromes P450: role in the metabolism and toxicology of drugs and other xenobiotics. London: Royal Society of Chemistry; 2008. p. 354-72
   Google Scholar
• Guengerich FP. Drug Metabolism as Catalyzed by Human Cytochrome P450 Enzymes. In: Sigel A, Sigel H, Siegel RKO, editors, The Unbiquitous Roles of Cytochrome P450 Proteins: Metal Ions in Life Sciences. Hoboken, NJ: Wiley; 2007. p. 561-84
   Google Scholar
• Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008;9(4):310-22
   PubMed Web of Science ®Google Scholar
• Li AP, Kaminski DL, Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995;104(1-3):1-8
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270(1):414-23
   PubMed Web of Science ®Google Scholar
• Zhou SF, Xue CC, Yu XQ, et al. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 2007;29(6):687-710
   PubMed Web of Science ®Google Scholar
• Yoshinari K, Tien E, Negishi M, Honkakoski P. Receptor-Mediated Regulation of Cytochrome P450. In: Ioannides C, editor, Cytochromes P450: Role in the Metabolism and Toxicology of Drugs and Other Xenobiotics. London: Royal Society of Chemistry; 2008. p. 418-39
   Google Scholar
• Plant N. The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks. Biochim Biophys Acta 2007;1770(3):478-88
   PubMed Web of Science ®Google Scholar
• Lim YP, Kuo SC, Lai ML, Huang JD. Inhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4alpha interaction. Pharmacogenet Genomics 2009;19(1):11-24
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab Dispos 2006;34(5):756-64
   PubMed Web of Science ®Google Scholar
• Burk O, Arnold KA, Nussler AK, et al. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 2005;67(6):1954-65
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007;47(5):566-78
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 1999;56(6):1329-39
   PubMed Web of Science ®Google Scholar
• Finta C, Zaphiropoulos PG. The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene 2000;260(1-2):13-23
   PubMed Web of Science ®Google Scholar
• Martínez-Jiménez CP, Gómez-Lechón MJ, Castell JV, Jover R. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/ enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein). Mol Pharmacol 2005;67(6):2088-101
   PubMed Web of Science ®Google Scholar
• Martínez-Jiménez CP, Jover R, Donato MT, et al. Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 2007;8(2):185-94
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Moore JT, Wade L, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998;92(1):73-82
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Goodwin B, Jones SA, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001;98(6):3369-74
   PubMed Web of Science ®Google Scholar
• Xie W, Radominska-Pandya A, Shi Y, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001;98(6):3375-80
   PubMed Web of Science ®Google Scholar
• Westlind-Johnsson A, Malmebo S, Johansson A, et al. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos 2003;31(6):755-61. 2003;31(6):755-61
   PubMed Web of Science ®Google Scholar
• Watkins RE, Wisely GB, Moore LB, et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 2001;292(5525):2329-33
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102(5):1016-23
   PubMed Web of Science ®Google Scholar
• Ma X, Idle JR, Gonzalez FJ. The pregnane X receptor: from bench to bedside. Expert Opin Drug Metab Toxicol 2008;4(7):895-908
   PubMed Web of Science ®Google Scholar
• Fukuen S, Fukuda T, Matsuda H, et al. Identification of the novel splicing variants for the hPXR in human livers. Biochem Biophys Res Commun 2002;298(3):433-8
   PubMed Web of Science ®Google Scholar
• Hustert E, Zibat A, Presecan-Siedel E, et al. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab Dispos 2001;29(11):1454-9
   PubMed Web of Science ®Google Scholar
• Squires EJ, Sueyoshi T, Negishi M. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem 2004;279(47):49307-14
   PubMed Web of Science ®Google Scholar
• Wan YJ, An D, Cai Y, et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000;20(12):4436-44
   PubMed Web of Science ®Google Scholar
• Matsumura K, Saito T, Takahashi Y, et al. Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 2004;65(2):326-3334
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Drocourt L, Fabre JM, et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000;58(2):361-72
   PubMed Web of Science ®Google Scholar
• Aouabdi S, Gibson G, Plant N. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab Dispos 2006;34(1):138-44
   PubMed Web of Science ®Google Scholar
• Ding X, Staudinger JL. Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway. J Pharmacol Exp Ther 2005;312(2):849-56
   PubMed Web of Science ®Google Scholar
• Ding X, Staudinger JL. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. Biochem Pharmacol 2005;69(5):867-73
   PubMed Web of Science ®Google Scholar
• Lin W, Wu J, Dong H, et al. Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells. J Biol Chem 2008;283(45):30650-7
   PubMed Web of Science ®Google Scholar
• Pondugula SR, Brimer-Cline C, Wu J, et al. A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor. Drug Metab Dispos 2009;37(4):719-30
   PubMed Web of Science ®Google Scholar
• Takagi S, Nakajima M, Mohri T, Yokoi T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 2008;283(15):9674-80
   PubMed Web of Science ®Google Scholar
• Baes M, Gulick T, Choi HS, et al. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 1994;14(3):1544-52
   PubMed Web of Science ®Google Scholar
• Lamba JK, Lamba V, Yasuda K, et al. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 2004;311(2):811-21
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Egan-Hafley M, et al. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000;407(6806):920-3
   PubMed Web of Science ®Google Scholar
• Moore JT, Moore LB, Maglich JM, Kliewer SA. Functional and structural comparison of PXR and CAR. Biochim Biophys Acta 2003;1619(3):235-8
   PubMed Web of Science ®Google Scholar
• Yoshinari K, Kobayashi K, Moore R, et al. Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett 2003;548(1-3):17-20
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Sueyoshi T, Inoue K, et al. Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol 2003;64(5):1069-75
   PubMed Web of Science ®Google Scholar
• Choi HS, Chung M, Tzameli I, et al. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem 1997;272(38):23565-71
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 2001;41:123-43
   PubMed Web of Science ®Google Scholar
• Maglich JM, Stoltz CM, Goodwin B, et al. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 2002;62(3):638-46
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Dowhan DH, et al. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J 2002;2(2):117-26
   PubMedGoogle Scholar
• Pascussi JM, Robert A, Moreau A, et al. Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4alpha isoforms. Hepatology 2007;45(5):1146-53
   PubMed Web of Science ®Google Scholar
• Koike C, Moore R, Negishi M. Extracellular signal-regulated kinase is an endogenous signal retaining the nuclear constitutive active/androstane receptor (CAR) in the cytoplasm of mouse primary hepatocytes. Mol Pharmacol 2007;71(5):1217-21
   PubMed Web of Science ®Google Scholar
• Woods CG, Heuvel JP, Rusyn I. Genomic profiling in nuclear receptor-mediated toxicity. Toxicol Pathol 2007;35(4):474-94
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Borgmeyer U, Heyman RA, et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992;6(3):329-44
   PubMed Web of Science ®Google Scholar
• Desvergne B. RXR: from partnership to leadership in metabolic regulations. Vitam Horm 2007;75:1-32
   PubMed Web of Science ®Google Scholar
• Kopf E, Plassat JL, Vivat V, et al. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J Biol Chem 2000;275(43):33280-8
   PubMed Web of Science ®Google Scholar
• Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004;328:1-16
   PubMed Web of Science ®Google Scholar
• Usui T, Saitoh Y, Komada F. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull 2003;26(4):510-7
   PubMed Web of Science ®Google Scholar
• El-Sankary W, Bombail V, Gibson GG, Plant N. Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 2002;30(9):1029-34
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Drocourt L, Gerbal-Chaloin S, et al. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 2001;268(24):6346-58
   PubMedGoogle Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003;1619(3):243-53
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, et al. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 2003;9(2):220-4
   PubMed Web of Science ®Google Scholar
• Cheng PY, Wang M, Morgan ET. Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J Pharmacol Exp Ther 2003;307(3):1205-12
   PubMed Web of Science ®Google Scholar
• Bombail V, Taylor K, Gibson GG, Plant N. Role of Sp1, C/EBP alpha, HNF3, and PXR in the basal- and xenobiotic-mediated regulation of the CYP3A4 gene. Drug Metab Dispos 2004;32(5):525-35
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Bort R, Jover R, et al. Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma. Mol Pharmacol 2003;63(5):1180-9
   PubMed Web of Science ®Google Scholar
• Zídek Z, Anzenbacher P, Kmoníčcková E. Current status and challenges of cytokine pharmacology. Br J Pharmacol 2009;157(3):342-61
   PubMed Web of Science ®Google Scholar
• Morgan ET, Goralski KB, Piquette-Miller M, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 2008;36(2):205-16
   PubMed Web of Science ®Google Scholar
• Aitken AE, Morgan ET. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos 2007;35(9):1687-93
   PubMed Web of Science ®Google Scholar
• Prandota J. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology. Am J Ther 2005;12(3):254-61
   PubMedGoogle Scholar
• Morgan ET. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 2009;85(4):434-8
   PubMed Web of Science ®Google Scholar
• Assenat E, Gerbal-Chaloin S, Larrey D, et al. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 2004;40(4):951-60
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gómez-Lechón MJ, Castell JV. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J 2002;16(13):1799-801
   PubMed Web of Science ®Google Scholar
• Gu X, Ke S, Liu D, et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 2006;281(26):17882-9
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Lichti K. Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease. Mol Pharm 2008;5(1):17-34
   PubMedGoogle Scholar
• Pascussi JM, Dvorák Z, Gerbal-Chaloin S, et al. Pathophysiological factors affecting CAR gene expression. Drug Metab Rev 2003;35(4):255-68
   PubMed Web of Science ®Google Scholar
• Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2004;2(1):4
   PubMedGoogle Scholar
• Li T, Jahan A, Chiang JY. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 2006;43(6):1202-10
   PubMed Web of Science ®Google Scholar
• Levitchi M, Fradette C, Bleau AM, et al. Signal transduction pathways implicated in the decrease in CYP1A1, 1A2 and 3A6 activity produced by serum from rabbits and humans with an inflammatory reaction. Biochem Pharmacol 2004;68(3):573-82
   PubMed Web of Science ®Google Scholar
• Hylemon PB, Zhou H, Pandak WM, et al. Bile acids as regulatory molecules. J Lipid Res 2006 [Epub ahead of print]
   Google Scholar
• Ghose R, White D, Guo T, et al. Regulation of hepatic drug-metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein. Drug Metab Dispos 2008;36(1):95-101
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. Role of NF-kappaB in the regulation of cytochrome p450 enzymes. Curr Drug Metab 2009;10(2):164-78
   PubMed Web of Science ®Google Scholar
• Zhou C, Tabb MM, Nelson EL, et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 2006;116(8):2280-9
   PubMed Web of Science ®Google Scholar
• Zangar RC, Bollinger N, Verma S, et al. The nuclear factor-kappa B pathway regulates cytochrome P450 3A4 protein stability. Mol Pharmacol 2008;73(6):1652-8
   PubMed Web of Science ®Google Scholar
• Zhu Y, Silverman RB. Revisiting heme mechanisms. A perspective on the mechanisms of nitric oxide synthase (NOS), Heme oxygenase (HO), and cytochrome P450s (CYP450s). Biochemistry 2008;47(8):2231-43
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Takemura S, Imaoka S, et al. Irreversible inhibition of cytochrome P450 by nitric oxide. J Pharmacol Exp Ther 1997;283(3):1479-85
   PubMed Web of Science ®Google Scholar
• Lee CM, Pohl J, Morgan ET. Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab Dispos 2009;37(4):865-72
   PubMed Web of Science ®Google Scholar
• Oesch-Bartlomowicz B, Oesch F. Phosphorylation of xenobiotic-metabolizing cytochromes P450. Anal Bioanal Chem 2008;392(6):1085-92
   PubMed Web of Science ®Google Scholar
• Aguiar M, Masse R, Gibbs BF. Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 2005;37(2):379-404
   PubMed Web of Science ®Google Scholar
• Neve EP, Ingelman-Sundberg M. Intracellular transport and localization of microsomal cytochrome P450. Anal Bioanal Chem 2008;392(6):1075-84
   PubMed Web of Science ®Google Scholar
• Correia MA, Sadeghi S, Mundo-Paredes E. Cytochrome P450 ubiquitination: branding for the proteolytic slaughter? Annu Rev Pharmacol Toxicol 2005;45:439-64
   PubMed Web of Science ®Google Scholar
• Wang Y, Liao M, Hoe N, et al. A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation. J Biol Chem 2009;284(9):5671-84
   PubMed Web of Science ®Google Scholar
• Wang X, Medzihradszky KF, Maltby D, Correia MA. Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: a mass spectrometric characterization of the phosphorylated peptides. Biochemistry 2001;40(38):11318-26
   PubMed Web of Science ®Google Scholar
• Oesch-Bartlomowicz B, Oesch F. Cytochrome-P450 phosphorylation as a functional switch. Arch Biochem Biophys 2003;409(1):228-34
   PubMed Web of Science ®Google Scholar
• Hosseinpour F, Moore R, Negishi M, Sueyoshi T. Serine 202 regulates the nuclear translocation of constitutive active/androstane receptor. Mol Pharmacol 2006;69(4):1095-102
   PubMed Web of Science ®Google Scholar
• Faouzi S, Medzihradszky KF, Hefner C, et al. Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97? Biochemistry 2007;46(26):7793-803
   PubMed Web of Science ®Google Scholar
• Pabarcus MK, Hoe N, Sadeghi S, et al. CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys 2009;483(1):66-74
   PubMed Web of Science ®Google Scholar
• Chen M, Gerlier D. Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy. Viral Immunol 2005;19(3):349-62
   Web of Science ®Google Scholar
• Dallaire F, Blanchette P, Groitl P, et al. Identification of Integrin {alpha}3 as a New Substrate of the Adenovirus E4orf6/E1B55K E3 Ubiquitin Ligase Complex. J Virol 2009;83(11):5329-38
   PubMed Web of Science ®Google Scholar
• Ichikawa Y, Hiwatashi A. The role of the sugar regions of components of the cytochrome P-450-linked mixed-function oxidase (monooxygenase) system of bovine adrenocortical mitochondria. Biochim Biophys Acta 1982;705(1):82-91
   PubMed Web of Science ®Google Scholar
• Armstrong RN, Pinto-Coelho C, Ryan DE, et al. On the glycosylation state of five rat hepatic microsomal cytochrome P-450 isozymes. J Biol Chem 1983;258(4):2106-8
   PubMed Web of Science ®Google Scholar
• Amarneh B, Corbin CJ, Peterson JA, et al. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol Endocrinol 1993;7(12):1617-24
   PubMed Web of Science ®Google Scholar
• Neu U, Stehle T, Atwood WJ. The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 2009;384(2):389-99
   PubMed Web of Science ®Google Scholar
• Arnberg N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 2009;19(3):165-78
   PubMed Web of Science ®Google Scholar
• Shors T. Virus Replication Cycles. Understanding Viruses Boston: Jones and Bartlett Publishers; 2009. p. 46-70
   Google Scholar
• Carter J, Saunders V. Transcription, Translation and Transport. Virology: Principles and Applications. Hoboken, NJ: Wiley; 2007. p. 69-84
   Google Scholar
• Netherton C, Moffat K, Brooks E, Wileman T. A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication. Adv Virus Res 2007;70:101-82
   PubMed Web of Science ®Google Scholar
• Wagner EK, Hewlett MJ, Bloon DC, Carmerini D. Human Immunodeficiency Virus Type I (HIV I) and Related Lentiviruses. Basic Virology. 3 edition. Malden, MA: Blackwell Publishing; 2008. p. 399-413
   Google Scholar
• Nassal M. Hepatitis B viruses: reverse transcription a different way. Virus Res 2008;134(1-2):235-49
   PubMed Web of Science ®Google Scholar
• Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999;284(5418):1313-8
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296(5566):298-300
   PubMed Web of Science ®Google Scholar
• Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3(2):169-76
   PubMed Web of Science ®Google Scholar
• Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol 2008;6(2):132-42
   PubMed Web of Science ®Google Scholar
• Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol 2005;116(2):241-9
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. First of two parts. N Engl J Med 2001;344(14):1058-66
   PubMed Web of Science ®Google Scholar
• Biron CA, Dalod M, Salazar-Mather TP. Innate Immunity and Viral Infections. In: Kaufman SHE, Sher A, Ahmed R, editors, Immunology of Infectious Diseases. Washington, D.C.: ASM Press; 2002. p. 139-60
   Google Scholar
• Koyama S, Ishii KJ, Coban C, Akira S. Innate immune response to viral infection. Cytokine 2008;43(3):336-41
   PubMed Web of Science ®Google Scholar
• Brandenburg B, Zhuang X. Virus trafficking - learning from single-virus tracking. Nat Rev Microbiol 2007;5(3):197-208
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Antiviral signaling through pattern recognition receptors. J Biochem 2007;141(2):137-45
   PubMed Web of Science ®Google Scholar
• Huang X, Yang Y. Innate immune recognition of viruses and viral vectors. Hum Gene Ther 2009;20(4):293-301
   PubMed Web of Science ®Google Scholar
• Akira S. TLR signaling. Curr Top Microbiol Immunol 2006;311:1-16
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchim O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;41(7089):101-5
   Google Scholar
• Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005;23(1):19-28
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4(7):499-511
   PubMed Web of Science ®Google Scholar
• Hoshino K, Sugiyama T, Matsumoto M, et al. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 2006;440(7086):949-53
   PubMed Web of Science ®Google Scholar
• Uematsu S, Akira S. Toll-like receptors and Type I interferons. J Biol Chem 2007;282(21):15319-23
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124(4):783-801
   PubMed Web of Science ®Google Scholar
• Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005;6(10):981-8
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. TLR Signaling. Cell Death Differ 2006;13:816-25
   PubMed Web of Science ®Google Scholar
• Richardson TA, Sherman M, Antonovic L, et al. Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metab Dispos 2006;34(3):354-60
   PubMed Web of Science ®Google Scholar
• Ghose R, Guo T, Haque N. Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. Arch Biochem Biophys 2009;481(1):123-30
   PubMed Web of Science ®Google Scholar
• Chaluvadi MR, Nyagode BA, Kinloch RD, Morgan ET. TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease. Biochem Pharmacol 2009;77(3):464-71
   PubMed Web of Science ®Google Scholar
• Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003;10(11):935-40
   PubMed Web of Science ®Google Scholar
• Bowen GP, Borgland SL, Lam M, et al. Adenovirus vector-induced inflammation:capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther 2002;13(3):367-79
   PubMed Web of Science ®Google Scholar
• Bruder JT, Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 1997;71(1):398-404
   PubMed Web of Science ®Google Scholar
• Tamanini A, Nicolis E, Bonizzato A, et al. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol 2006;80(22):11241-54
   PubMed Web of Science ®Google Scholar
• Tibbles LA, Spurrell JC, Bowen GP, et al. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol 2002;76(4):1559-68
   PubMed Web of Science ®Google Scholar
• Szomolanyi-Tsuda E, Brehm MA, Welsh RM. Acquired Immunity Against Viral Infections. In: Kaufman SHE, Sher A, Ahmed R, editor, Immunology of Infectious Disease. Washington, D.C.: ASM Press; 2002. p. 247-65
   Google Scholar
• Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91
   PubMed Web of Science ®Google Scholar
• Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996;6(1):1-42
   PubMedGoogle Scholar
• Bogaards JJ, Bertrand M, Jackson P, et al. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000;30(12):1131-52
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2006;2(6):875-94
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem Biol Interact 1997;106(3):161-82
   PubMed Web of Science ®Google Scholar
• Muruganandan S, Sinal CJ. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism. Clin Pharmacol Ther 2008;83(6):818-28
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Lecluyse EL, Ferguson SS. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica 2007;37(10-11):1196-224
   PubMed Web of Science ®Google Scholar
• Capecchi MR. The new mouse genetics: altering the genome by gene targeting. Trends Genet 1989;5(3):70-6
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Wagenaar E, van der Kruijssen CM, et al. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J Clin Invest 2007;117(11):3583-92
   PubMed Web of Science ®Google Scholar
• Cheung C, Gonzalez FJ. Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment. J Pharmacol Exp Ther 2008;327(2):288-99
   PubMed Web of Science ®Google Scholar
• Scheer N, Ross J, Rode A, et al. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J Clin Invest 2008;118(9):3228-39
   PubMed Web of Science ®Google Scholar
• Felmlee MA, Lon HK, Gonzalez FJ, Yu AM. Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice. Drug Metab Dispos 2008;36(2):435-41
   PubMed Web of Science ®Google Scholar
• Ma X, Cheung C, Krausz KW, et al. A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4. Drug Metab Dispos 2008;36(12):2506-12
   PubMed Web of Science ®Google Scholar
• Dandri M, Burda MR, Török E, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001;33(4):981-8
   PubMed Web of Science ®Google Scholar
• Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001;7(8):927-33
   PubMed Web of Science ®Google Scholar
• Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004;165(3):901-12
   PubMed Web of Science ®Google Scholar
• Katoh M, Tateno C, Yoshizato K, Yokoi T. Chimeric mice with humanized liver. Toxicology 2008;246(1):9-17
   PubMed Web of Science ®Google Scholar
• Sinz M, Wallace G, Sahi J. Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. AAPS J 2008;10(2):391-400
   PubMed Web of Science ®Google Scholar
• Donato MT, Lahoz A, Castell JV, Gómez-Lechón MJ. Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 2008;9(1):1-11
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Lechón MJ, Houston JB, et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 2007;39(1):159-234
   PubMed Web of Science ®Google Scholar
• Kojima K, Nagata K, Matsubara T, Yamazoe Y. Broad but distinct role of pregnane X receptor on the expression of individual cytochrome p450s in human hepatocytes. Drug Metab Pharmacokinet 2007;22(4):276-86
   PubMed Web of Science ®Google Scholar
• Clayton RF, Rinaldi A, Kandyba EE, et al. Liver cell lines for the study of hepatocyte functions and immunological response. Liver Int 2005;25(2):389-402
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Hewitt P. Phase I and II enzyme characterization of two sources of HepG2 cell lines. Xenobiotica 2004;34(3):243-56
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Donato MT, Boobis A, et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 2002;32(6):505-20
   PubMed Web of Science ®Google Scholar
• Rencurel F, Stenhouse A, Hawley SA, et al. AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J Biol Chem 2005;280(6):4367-73
   PubMed Web of Science ®Google Scholar
• Gómez-Lechón MJ, Donato T, Jover R, et al. Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. Eur J Biochem 2001;268(5):1448-59
   PubMedGoogle Scholar
• Guillouzo A, Corlu A, Aninat C, et al. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 2007;168(1):66-73
   PubMed Web of Science ®Google Scholar
• McGinnity DF, Zhang G, Kenny J, et al. Evaluation of multiple in vitro systems for assessment of CYP3A4 Induction in Drug Discovery: human hepatocytes, PXR reporter gene, Fa2N-4 and HepaRG cells. Drug Metab Dispos 2009. [Epub ahead of print]
   PubMedGoogle Scholar
• Hengstler JG, Brulport M, Schormann W, et al. Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 2005;1(1):61-74
   PubMedGoogle Scholar
• Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109(10):1291-302
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Ungefroren H, Nussler A, et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005;128(7):1774-86
   PubMed Web of Science ®Google Scholar
• Ehnert S, Nussler AK, Lehmann A, Dooley S. Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism. Drug Metab Dispos 2008;36(9):1922-9
   PubMed Web of Science ®Google Scholar
• Tuschl G, Lauer B, Mueller SO. Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opin Drug Metab Toxicol 2008;4(7):855-70
   PubMed Web of Science ®Google Scholar
• Li AP. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 2007;168(1):16-29
   PubMed Web of Science ®Google Scholar
• Lim PL, Tan W, Latchoumycandane C, et al. Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04. Toxicol In Vitro 2007;21(8):1390-401
   PubMed Web of Science ®Google Scholar
• Castell JV, Gómez-Lechón MJ. Liver cell culture techniques. Methods Mol Biol 2009;481:35-46
   PubMedGoogle Scholar
• Lake BG, Price RJ, Giddings AM, Walters DG. In vitro assays for induction of drug metabolism. Methods Mol Biol 2009;481:47-58
   PubMedGoogle Scholar
• Elaut G, Henkens T, Papeleu P, et al. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab 2006;7(6):629-60
   PubMed Web of Science ®Google Scholar
• Hansen LK, Wilhelm J, Fassett JT. Regulation of hepatocyte cell cycle progression and differentiation by type I collagen structure. Curr Top Dev Biol 2006;72:205-36
   PubMed Web of Science ®Google Scholar
• Shellie M. Callahan. Recombinant Adenoviral-Mediated Alterations of Cytochrome P450 3A2 and 2C11. Ph.D. dissertation, The Univeristy of Texas at Austin, 2005:128-65
   Google Scholar
• Milosevic N, Schawalder H, Maier P. Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. Eur J Pharmacol 1999;368:75-87
   PubMed Web of Science ®Google Scholar
• Smedsrød B, Pertoft H. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J Leukoc Biol 1985;38(2):213-30
   PubMed Web of Science ®Google Scholar
• Castell JV, Jover R, Martønez-Jiménez CP, Gómez-Lechón MJ. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol 2006;2(2):183-212
   PubMed Web of Science ®Google Scholar
• Persson KP, Ekehed S, Otter C, et al. Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans. Pharm Res 2006;23(1):56-69
   PubMed Web of Science ®Google Scholar
• Harmsen S, Meijerman I, Beijnen JH, Schellens JH. Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor. Cancer Chemother Pharmacol 2009;64(1):35-43
   PubMed Web of Science ®Google Scholar
• Kozawa M, Honma M, Suzuki H. Quantitative prediction of in vivo profiles of CYP3A4 induction in humans from in vitro results with reporter gene assay. Drug Metab Dispos 2009;37(6):1234-41
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009;8(2):129-38
   PubMed Web of Science ®Google Scholar
• Schaffer DV, Koerber JT, Lim KI. Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng 2008;10:169-94
   PubMed Web of Science ®Google Scholar
• Cattaneo R, Miest T, Shashkova EV, Barry MA. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol 2008;6(7):529-40
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Wedzicha JA. Viral infections in obstructive airway diseases. Curr Opin Pulm Med 2003;9(2):111-6
   PubMed Web of Science ®Google Scholar
• Humar A. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation 2006;82(2S):S9-14
   PubMedGoogle Scholar
• Callahan SM, Ming X, Lu SK, et al. Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450. J Pharmacol Exp Ther 2005;312(2):492-501
   PubMed Web of Science ®Google Scholar
• Callahan SM, Wonganan P, Croyle MA. Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection. Virol J 2008;5:111
   PubMed Web of Science ®Google Scholar
• Croyle MA, Chirmule N, Zhang Y, Wilson JM. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum Gene Ther 2002;13(15):1887-900
   PubMed Web of Science ®Google Scholar
• Croyle MA, Chirmule N, Zhang Y, Wilson JM. “Stealth” adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 2001;75(10):4792-801
   PubMed Web of Science ®Google Scholar
• Douglas JT. Adenoviral vectors for gene therapy. Mol Biotechnol 2007;36(1):71-80
   PubMed Web of Science ®Google Scholar
• Le HT, Boquet MP, Clark EA, et al. Renal pathophysiology after systemic administration of recombinant adenovirus: changes in renal cytochromes P450 based on vector dose. Hum Gene Ther 2006;17(11):1095-111
   PubMed Web of Science ®Google Scholar
• Callahan SM, Boquet MP, Ming X, et al. Impact of transgene expression on drug metabolism following systemic adenoviral vector administration. J Gene Med 2006;8(5):566-76
   PubMed Web of Science ®Google Scholar
• Wonganan P, Zamboni WC, Strychor S, et al. Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model. Cancer Gene Ther 2009;16(5):405-14
   PubMed Web of Science ®Google Scholar
• Suomalainen M, Nakano MY, Boucke K, et al. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J 2001;20(6):1310-9
   PubMed Web of Science ®Google Scholar
• Meier O, Greber U. Adenovirus endocytosis. J Gene Med 2003;5(6):451-62
   PubMed Web of Science ®Google Scholar
• Zimmerman TL, Thevananther S, Ghose R, et al. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 2006;281(22):15434-40
   PubMed Web of Science ®Google Scholar
• Hartman ZC, Appledorn DM, Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 2008;132(1-2):1-14
   PubMed Web of Science ®Google Scholar
• Dupuy AG, Caron E. Integrin-dependent phagocytosis: spreading from microadhesion to new concepts. J Cell Sci 2008;121(Pt 11):1173-83
   Google Scholar
• Greber UF. Signalling in viral entry. Cell Mol Life Sci 2002;59(4):608-26
   PubMed Web of Science ®Google Scholar
• Evans R, Patzak I, Svensson L, et al. Integrins in immunity. J Cell Sci 2009;122(Pt 2):212-25
   Google Scholar
• Häussinger D, Reinehr R, Schliess F. The hepatocyte integrin system and cell volume sensing. Acta Physiol 2006;187(1-2):249-55
   PubMed Web of Science ®Google Scholar
• Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci 2009;122(Pt 2):159-63
   PubMed Web of Science ®Google Scholar
• Streuli CH, Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J 2009;418(3):491-506
   PubMed Web of Science ®Google Scholar